JP2009517356A5 - - Google Patents

Download PDF

Info

Publication number
JP2009517356A5
JP2009517356A5 JP2008541658A JP2008541658A JP2009517356A5 JP 2009517356 A5 JP2009517356 A5 JP 2009517356A5 JP 2008541658 A JP2008541658 A JP 2008541658A JP 2008541658 A JP2008541658 A JP 2008541658A JP 2009517356 A5 JP2009517356 A5 JP 2009517356A5
Authority
JP
Japan
Prior art keywords
composition
agent
therapeutic agent
composition according
phenylalanine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008541658A
Other languages
English (en)
Japanese (ja)
Other versions
JP5108781B2 (ja
JP2009517356A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2006/011367 external-priority patent/WO2007060011A1/en
Publication of JP2009517356A publication Critical patent/JP2009517356A/ja
Publication of JP2009517356A5 publication Critical patent/JP2009517356A5/ja
Application granted granted Critical
Publication of JP5108781B2 publication Critical patent/JP5108781B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008541658A 2005-11-25 2006-11-27 悪性新形成の治療 Active JP5108781B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05025776 2005-11-25
EP05025776.5 2005-11-25
PCT/EP2006/011367 WO2007060011A1 (en) 2005-11-25 2006-11-27 Therapy of malignant neoplasias

Publications (3)

Publication Number Publication Date
JP2009517356A JP2009517356A (ja) 2009-04-30
JP2009517356A5 true JP2009517356A5 (https=) 2010-01-21
JP5108781B2 JP5108781B2 (ja) 2012-12-26

Family

ID=37744207

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008541658A Active JP5108781B2 (ja) 2005-11-25 2006-11-27 悪性新形成の治療

Country Status (15)

Country Link
US (1) US8268888B2 (https=)
EP (1) EP1962822B1 (https=)
JP (1) JP5108781B2 (https=)
KR (1) KR20080074193A (https=)
AT (1) ATE454144T1 (https=)
AU (1) AU2006316781B2 (https=)
CA (1) CA2630848C (https=)
DE (1) DE602006011650D1 (https=)
DK (1) DK1962822T3 (https=)
ES (1) ES2341575T3 (https=)
IL (1) IL191690A (https=)
NZ (1) NZ568367A (https=)
PL (1) PL1962822T3 (https=)
PT (1) PT1962822E (https=)
WO (1) WO2007060011A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2948154C (en) 2014-05-07 2017-09-26 The University Of Akron Radioopaque, iodine functionalized phenylalanine-based poly(ester urea)s
WO2025202716A1 (en) * 2024-03-26 2025-10-02 Telix Pharmaceuticals (Innovations) Pty Ltd Combination therapy for treating glioblastomas

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5816999A (en) * 1997-07-24 1998-10-06 Bischoff; Jeffrey Flexible catheter for the delivery of ionizing radiation to the interior of a living body
AU1932900A (en) * 1998-12-04 2000-06-26 Medivas, Llc Methods for detection of vulnerable plaques using a detectable lipid-avid agent
WO2004050168A2 (en) * 2002-11-27 2004-06-17 Board Of Regents, The University Of Texas System Radiopharmaceuticals and radioactive microspheres for locoregional ablation of abnormal tissues

Similar Documents

Publication Publication Date Title
Zhang et al. Advancements of radiotherapy for recurrent head and neck cancer in modern era
Hainfeld et al. The use of gold nanoparticles to enhance radiotherapy in mice
JP4729503B2 (ja) 抗癌剤の奏効率増強剤
Brandes et al. EORTC study 26041-22041: phase I/II study on concomitant and adjuvant temozolomide (TMZ) and radiotherapy (RT) with PTK787/ZK222584 (PTK/ZK) in newly diagnosed glioblastoma
ES2738512T3 (es) Formulación farmacéutica para tratar cáncer de páncreas
US20130266508A1 (en) Thermosensitive hydrogel for coating radioisotope and chemotherapeutic agent to treat cancer and method for preparing the same
JP2020523359A5 (https=)
Yan et al. Engineering immunogenic cell death with nanosized drug delivery systems improving cancer immunotherapy
JP2016515586A5 (https=)
IL259512B1 (en) Combination for effective treatment of metastatic cancer in patients
Yi et al. Emerging strategies based on nanomaterials for ionizing radiation-optimized drug treatment of cancer
Symonds et al. Principles of chemotherapy and radiotherapy
US20170304648A1 (en) Photodynamic compounds and methods for activating them using ionizing radiation and/or other electromagnetic radiation for therapy and/or diagnostics
US20210283255A1 (en) Reducing Damage From Chemotherapy And Increasing Cancer Kill Rates By Using Interweaved Low Dose Radiation
JP2009517356A5 (https=)
Paoletti Therapeutic strategy for central nervous system tumors: present status, criticism and potential
Huh et al. Therapeutic effects of Holmium-166 chitosan complex in rat brain tumor model
CN111407748B (zh) 酪醇在制备治疗脑胶质瘤的药物中的应用
CN111494385B (zh) 一种治疗卵巢癌的药物及其制备方法和用途
US20080038376A1 (en) Anti-cancer composition and method for using the same
CN106668061B (zh) 一种含有顺铂的抗癌药物组合物
RU2834842C2 (ru) Способ лечения рецидивов высокозлокачественных глиом головного мозга
Toma et al. Concomitant radiation-Doxorubicin administration in locally advanced and/or metastatic soft tissue sarcomas
Boz et al. Radiotherapy and chemotherapy in pancreatic cancer. Topical issues and future perspectives
Nour et al. Application of Radiosensitizers in Cancer Radiotherapy, Nanomaterials of Heavy Metals, Drugs and Chemicals with Nanostructure